Vaccines and therapeutics for immunocompromised patients with COVID-19
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …
This diverse group is at increased risk for impaired vaccine responses, progression to …
The immune response to SARS-CoV-2 in people with HIV
MA Höft, WA Burgers, C Riou - Cellular & Molecular Immunology, 2024 - nature.com
This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel
Importance Recent advances in treatment and prevention of HIV warrant updated
recommendations to guide optimal practice. Objective Based on a critical evaluation of new …
recommendations to guide optimal practice. Objective Based on a critical evaluation of new …
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
KS Hensley, MJ Jongkees, D Geers… - PLoS …, 2022 - journals.plos.org
Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …
COVID-19: Clinical features
K McIntosh, MS Hirsch, A Bloom - Uptodate Version, 2021 - uptodate.com
Coronaviruses are important human and animal pathogens. At the end of 2019, a novel
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …
Information note on HIV and COVID-19
World Health Organization - 2020 - apps.who.int
People living with HIV depend on life-saving antiretroviral therapy ( ART) and access to ART
must be maintained during periods of travel restrictions and lockdowns resulting from the …
must be maintained during periods of travel restrictions and lockdowns resulting from the …
Immunologic interplay between HIV/AIDS and COVID-19: adding fuel to the flames?
M Augello, V Bono, R Rovito, C Tincati… - Current HIV/AIDS …, 2023 - Springer
Abstract Purpose of Review HIV/AIDS and COVID-19 have been the major pandemics
overwhelming our times. Given the enduring immune disfunction featuring people living with …
overwhelming our times. Given the enduring immune disfunction featuring people living with …
Incidence and predictors of breakthrough and severe breakthrough infections of SARS-CoV-2 after primary series vaccination in adults: a population-based survey of …
SM DeSantis, A Yaseen, T Hao… - The Journal of …, 2023 - academic.oup.com
Background Breakthrough infections of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are well documented. The current study estimates breakthrough incidence …
(SARS-CoV-2) are well documented. The current study estimates breakthrough incidence …
Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy
HR Lapointe, F Mwimanzi, PK Cheung, Y Sang… - Aids, 2023 - journals.lww.com
Background: Limited data exist regarding longer term antibody responses following three-
dose coronavirus disease 2019 (COVID-19) vaccination, and the impact of a first SARS-CoV …
dose coronavirus disease 2019 (COVID-19) vaccination, and the impact of a first SARS-CoV …
Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with HIV with hyporesponse after primary vaccination
MJ Jongkees, D Geers, KS Hensley… - The Journal of …, 2023 - academic.oup.com
Background The COVIH study is a prospective coronavirus disease 2019 (COVID-19)
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody …
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody …